Literature DB >> 22225407

The role of mycelium production and a MAPK-mediated immune response in the C. elegans-Fusarium model system.

Maged Muhammed1, Beth Burgwyn Fuchs, Michael P Wu, Julia Breger, Jeffrey J Coleman, Eleftherios Mylonakis.   

Abstract

Fusariosis is an emerging infectious complication of immune deficiency, but models to study this infection are lacking. The use of the soil nematode Caenorhabditis elegans as a model host to study the pathogenesis of Fusarium spp. was investigated. We observed that Fusarium conidia consumed by C. elegans can cause a lethal infection and result in more than 90% killing of the host within 120 hours, and the nematode had a significantly longer survival when challenged with Fusarium proliferatum compared to other species. Interestingly, mycelium production appears to be a major contributor in nematode killing in this model system, and C. elegans mutant strains with the immune response genes, tir-1 (encoding a protein containing a TIR domain that functions upstream of PMK-1) and pmk-1 (the homolog of the mammalian p38 MAPK) lived significantly shorter when challenged with Fusarium compared to the wild type strain. Furthermore, we used the C. elegans model to assess the efficacy and toxicity of various compounds against Fusarium. We demonstrated that amphotericin B, voriconazole, mancozeb, and phenyl mercury acetate significantly prolonged the survival of Fusarium-infected C. elegans, although mancozeb was toxic at higher concentrations. In conclusion, we describe a new model system for the study of Fusarium pathogenesis and evolutionarily preserved host responses to this important fungal pathogen.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22225407      PMCID: PMC3759989          DOI: 10.3109/13693786.2011.648217

Source DB:  PubMed          Journal:  Med Mycol        ISSN: 1369-3786            Impact factor:   4.076


  60 in total

1.  Formation of fumonisins and other secondary metabolites by Fusarium oxysporum and F. proliferatum: a comparative study.

Authors:  A Waskiewicz; P Golinski; Z Karolewski; L Irzykowska; J Bocianowski; M Kostecki; Z Weber
Journal:  Food Addit Contam Part A Chem Anal Control Expo Risk Assess       Date:  2010-05

Review 2.  ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions.

Authors:  Philippe P Roux; John Blenis
Journal:  Microbiol Mol Biol Rev       Date:  2004-06       Impact factor: 11.056

3.  Treatment of non-Aspergillus moulds in immunocompromised patients, with amphotericin B lipid complex.

Authors:  John R Perfect
Journal:  Clin Infect Dis       Date:  2005-05-01       Impact factor: 9.079

4.  High-throughput screen for novel antimicrobials using a whole animal infection model.

Authors:  Terence I Moy; Annie L Conery; Jonah Larkins-Ford; Gang Wu; Ralph Mazitschek; Gabriele Casadei; Kim Lewis; Anne E Carpenter; Frederick M Ausubel
Journal:  ACS Chem Biol       Date:  2009-07-17       Impact factor: 5.100

5.  Outcome predictors of 84 patients with hematologic malignancies and Fusarium infection.

Authors:  Marcio Nucci; Elias J Anaissie; Flavio Queiroz-Telles; Carlos A Martins; Plínio Trabasso; Cristiana Solza; Claudia Mangini; Belinda P Simões; Arnaldo L Colombo; Jorge Vaz; Carlos E Levy; Silvia Costa; Vaneusa A Moreira; José Salvador Oliveira; Nestor Paraguay; Gisele Duboc; Julio C Voltarelli; Angelo Maiolino; Ricardo Pasquini; Cármino A Souza
Journal:  Cancer       Date:  2003-07-15       Impact factor: 6.860

Review 6.  Fusarium infections in immunocompromised patients.

Authors:  Marcio Nucci; Elias Anaissie
Journal:  Clin Microbiol Rev       Date:  2007-10       Impact factor: 26.132

7.  Candida albicans infection of Caenorhabditis elegans induces antifungal immune defenses.

Authors:  Read Pukkila-Worley; Frederick M Ausubel; Eleftherios Mylonakis
Journal:  PLoS Pathog       Date:  2011-06-23       Impact factor: 6.823

8.  Resolution of disseminated fusariosis in a child with acute leukemia treated with combined antifungal therapy: a case report.

Authors:  José-Manuel Vagace; Cesar Sanz-Rodriguez; Maria-Soledad Casado; Nieves Alonso; Manuel Garcia-Dominguez; Francisco Garcia de la Llana; Luis Zarallo; Miguel Fajardo; Roberto Bajo
Journal:  BMC Infect Dis       Date:  2007-05-10       Impact factor: 3.090

9.  Anti-fungal innate immunity in C. elegans is enhanced by evolutionary diversification of antimicrobial peptides.

Authors:  Nathalie Pujol; Olivier Zugasti; Daniel Wong; Carole Couillault; C Léopold Kurz; Hinrich Schulenburg; Jonathan J Ewbank
Journal:  PLoS Pathog       Date:  2008-07-18       Impact factor: 6.823

10.  Identification of antifungal compounds active against Candida albicans using an improved high-throughput Caenorhabditis elegans assay.

Authors:  Ikechukwu Okoli; Jeffrey J Coleman; Emmanouil Tampakakis; Emmanouil Tempakakis; W Frank An; Edward Holson; Florence Wagner; Annie L Conery; Jonah Larkins-Ford; Gang Wu; Andy Stern; Frederick M Ausubel; Eleftherios Mylonakis
Journal:  PLoS One       Date:  2009-09-14       Impact factor: 3.240

View more
  14 in total

Review 1.  Caenorhabditis elegans as a model animal for investigating fungal pathogenesis.

Authors:  Moses Madende; Jacobus Albertyn; Olihile Sebolai; Carolina H Pohl
Journal:  Med Microbiol Immunol       Date:  2019-09-25       Impact factor: 3.402

2.  Activity of caffeic acid phenethyl ester in Caenorhabditis elegans.

Authors:  Jeffrey J Coleman; Tomomi Komura; Julia Munro; Michael P Wu; Rakhee R Busanelli; Angela N Koehler; Méryl Thomas; Florence F Wagner; Edward B Holson; Eleftherios Mylonakis
Journal:  Future Med Chem       Date:  2016-10-14       Impact factor: 3.808

3.  Transcript pattern analysis of Arf-family genes in the phytopathogen Fusarium oxysporum f. sp. lycopersici reveals the role of Arl3 in the virulence.

Authors:  Carlos A Araiza-Cervantes; Marco I Valle-Maldonado; J Alberto Patiño-Medina; Viridiana Alejandre-Castañeda; Juan B Guzmán-Pérez; Martha I Ramírez-Díaz; Karla L Macias-Sánchez; Manuel S López-Berges; Víctor Meza-Carmen
Journal:  Antonie Van Leeuwenhoek       Date:  2021-08-02       Impact factor: 2.271

4.  Comparative genomics RNAi screen identifies Eftud2 as a novel regulator of innate immunity.

Authors:  Lesly De Arras; Rebecca Laws; Sonia M Leach; Kyle Pontis; Jonathan H Freedman; David A Schwartz; Scott Alper
Journal:  Genetics       Date:  2013-12-20       Impact factor: 4.562

5.  An evolutionarily conserved innate immunity protein interaction network.

Authors:  Lesly De Arras; Amara Seng; Brad Lackford; Mohammad R Keikhaee; Bruce Bowerman; Jonathan H Freedman; David A Schwartz; Scott Alper
Journal:  J Biol Chem       Date:  2012-12-03       Impact factor: 5.157

6.  Cultivable fungi present in deep-sea sediments of Antarctica: taxonomy, diversity, and bioprospecting of bioactive compounds.

Authors:  Mayara B Ogaki; Lívia C Coelho; Rosemary Vieira; Arthur A Neto; Carlos L Zani; Tânia M A Alves; Policarpo A S Junior; Silvane M F Murta; Emerson C Barbosa; Jaquelline G Oliveira; Isabela P Ceravolo; Patrícia O Pereira; Betania B Cota; Roberta O Viana; Viviane S Alves; Luiz H Rosa
Journal:  Extremophiles       Date:  2019-11-22       Impact factor: 2.395

7.  Limiting of the innate immune response by SF3A-dependent control of MyD88 alternative mRNA splicing.

Authors:  Lesly De Arras; Scott Alper
Journal:  PLoS Genet       Date:  2013-10-24       Impact factor: 5.917

8.  Impact of Resistance to Fluconazole on Virulence and Morphological Aspects of Cryptococcus neoformans and Cryptococcus gattii Isolates.

Authors:  Suélen A Rossi; Nuria Trevijano-Contador; Liliana Scorzoni; Ana Cecilia Mesa-Arango; Haroldo C de Oliveira; Karin Werther; Tânia de Freitas Raso; Maria J S Mendes-Giannini; Oscar Zaragoza; Ana M Fusco-Almeida
Journal:  Front Microbiol       Date:  2016-02-16       Impact factor: 5.640

Review 9.  Diversity, evolution and medical applications of insect antimicrobial peptides.

Authors:  Eleftherios Mylonakis; Lars Podsiadlowski; Maged Muhammed; Andreas Vilcinskas
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2016-05-26       Impact factor: 6.237

10.  Antifungal efficacy during Candida krusei infection in non-conventional models correlates with the yeast in vitro susceptibility profile.

Authors:  Liliana Scorzoni; Maria Pilar de Lucas; Ana Cecilia Mesa-Arango; Ana Marisa Fusco-Almeida; Encarnación Lozano; Manuel Cuenca-Estrella; Maria Jose Mendes-Giannini; Oscar Zaragoza
Journal:  PLoS One       Date:  2013-03-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.